Keybanc analyst Josh Beck maintains Alkami Technology (NASDAQ:ALKT) with a Overweight and raises the price target from $16 to $18.
Keybanc Maintains Overweight on Alkami Technology, Raises Price Target to $18
Keybanc analyst Josh Beck maintains Alkami Technology (NASDAQ:ALKT) with a Overweight and raises the price target from $16 to $18.
Related Posts
Here’s How Much You Would Have Made Owning Travelers Companies Stock In The Last 15 Years
Travelers Companies (NYSE:TRV) has outperformed the market over the past 15 years by 1.98% on an annualized basis producing an average annual return of 8.04%. Currently, Travelers Companies has a market capitalization of $39.11 billion.
Mizuho Maintains Buy on Mobileye Global, Raises Price Target to $42
Mizuho analyst Vijay Rakesh maintains Mobileye Global (NASDAQ:MBLY) with a Buy and raises the price target from $40 to $42.
Truist Securities Maintains Buy on Amedisys, Lowers Price Target to $140
Truist Securities analyst David Macdonald maintains Amedisys (NASDAQ:AMED) with a Buy and lowers the price target from $150 to $140.